NKG2D chimeric antigen receptor-T cells to target GBM.

被引：0
|
作者：
Dai, Hong-jiu
Yang, Dong
Sun, Bin
Shi, Lan
Zhang, Pei-xian
Zhao, Xu-dong
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2034
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2034
引用
收藏
页数：1
相关论文
共 50 条
  • [21] NKG2D Car Redirected T Cells Target Osteosarcoma Cells
    Fernandez, L.
    Metais, J. Y.
    Valentin, J.
    Campana, D.
    Leung, W.
    Perez-Martinez, A.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S66 - S67
  • [22] The update of chimeric antigen receptor-T cells therapy in glioblastoma
    Chou, Chi-Jen
    Lin, Chun-Fu
    Chen, Yi-Wei
    Huang, Pin-, I
    Yang, Yi-Ping
    Wang, Mong-Lien
    Hung, Kai-Feng
    Lee, Yi-Yen
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (05) : 442 - 445
  • [23] Engineering chimeric antigen receptor-T cells for cancer treatment
    Baixin Ye
    Creed M. Stary
    Xuejun Li
    Qingping Gao
    Chunsheng Kang
    Xiaoxing Xiong
    Molecular Cancer, 17
  • [24] Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells
    A Barber
    K R Meehan
    C L Sentman
    Gene Therapy, 2011, 18 : 509 - 516
  • [25] Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor
    Zhang, Tong
    Barber, Amorette
    Sentman, Charles L.
    CANCER RESEARCH, 2006, 66 (11) : 5927 - 5933
  • [26] Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells
    Barber, A.
    Meehan, K. R.
    Sentman, C. L.
    GENE THERAPY, 2011, 18 (05) : 509 - 516
  • [27] Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy
    Murad, Joana M.
    Baumeister, Susanne H.
    Werner, Lillian
    Daley, Heather
    Trebeden-Negre, Helene
    Reder, Jake
    Sentman, Charles L.
    Gilham, David
    Lehmann, Frederic
    Snykers, Sarah
    Sentman, Marie-Louise
    Wade, Terri
    Schmucker, Adam
    Fanger, Michael W.
    Dranoff, Glenn
    Ritz, Jerome
    Nikiforow, Sarah
    CYTOTHERAPY, 2018, 20 (07) : 952 - 963
  • [28] NKG2D Car T Cells are not affected by Soluble NKG2D Ligands
    Fernandez, Adrian
    Fernandez, Lucia
    Mirones, Isabel
    Escudero, Adela
    Cardoso, Leila
    Esteso, Gloria
    De Paz, Raquel
    Martinez-Lopez, Joaquin
    Vales, Mar
    Perez-Martinez, Antonio
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 243 - 243
  • [29] T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice
    VanSeggelen, Heather
    Hammill, Joanne A.
    Dvorkin-Gheva, Anna
    Tantalo, Daniela G. M.
    Kwiecien, Jacek M.
    Denisova, Galina F.
    Rabinovich, Brian
    Wan, Yonghong
    Bramson, Jonathan L.
    MOLECULAR THERAPY, 2015, 23 (10) : 1600 - 1610
  • [30] Generation and Functional Verification of Hypoxiasensitive Chimeric Antigen Receptor-T Cells
    Xue, Ying
    Mao, Yunyu
    Liao, Qibin
    Zhao, Chen
    Zhang, Xiaoyan
    Xu, Jianqing
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2024, (208):
12345